This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

The Deal: J.C. Penney Pitches Poison Pill

NEW YORK ( The Deal) -- Retailer J.C. Penney (JCP - Get Report) said Thursday, Aug. 22, it has adopted a shareholder rights plan to ward off takeover efforts, days after reporting its sixth consecutive quarterly loss.

Plano, Texas-based Penney said that the stockholder rights plan will be in effect for one year, and "is designed to protect against any potential future use of coercive or abusive takeover techniques and to help ensure that the company's stockholders are not deprived of the opportunity to realize the full and fair value of their investment."

Penney said the plan was not adopted in response to any effort to gain control the company.

The announcement comes after Penney reported a worse-than-expected net loss of $586 million, including charges. Net sales fell 12% year-over-year, and gross margins fell during the quarter. The company earlier this year appointed Mike Ullman to try to reverse a ruinous turnaround strategy instituted by one time Apple executive Ron Johnson that Penney now blames for its sales woes.

Penney earlier this month said that activist hedge fund manager William Ackman, an early supporter of Johnson, was stepping down from the board. Ackman's Pershing Square Capital Management LP holds about 17.7% of Penney and, as part of the investor's resignation from the board, has agreed to a blackout period precluding him from selling shares.

The retailer said its poison pill includes rights to buy shares that would be exercisable only if a person or group acquires more than 10% of its common stock or commences a tender offer. Pershing Square and Vornado Realty Trust, another large holder, are not covered under the plan so long as they follow agreements in place with the company.

Shares of Penney traded up 1%, or 13 cents, to $13.33. in premarket trading. The company has lost more than half of its value in the last year, and traded above $40 per share as recently as early 2012.

--Written by Lou Whiteman

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
JCP $9.28 0.00%
AAPL $93.74 0.00%
FB $117.58 0.00%
GOOG $693.01 0.00%
TSLA $240.76 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs